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Background:  Transcatheter aortic valve implantation (TAVI) is a treatment option for patients with severe aortic stenosis. We aimed to investigate 
per procedure changes in LV systolic and diastolic performance during TAVI in high risk patients, and hypothesized that TAVI immediately improves LV 
systolic and diastolic function.
Methods:  Nine (2 women) consecutive patients aged (mean±SD) 77±8 years treated with the transapical aortic valve replacement technique 
in general anesthesia were studied after induction of anesthesia (BL) and 15 min post TAVI. All had severe symptomatic aortic stenosis (valve area 
0.69±0.20 cm2, transvalvular gradient 51±9 mmHg). In all, surgical treatment was declined due to high risk (Log Euroscore 28±14). Four patients 
had pre procedure PCI. Transoesophageal echocardiography was used to obtain mitral ring systolic velocities (S’) and the diastolic mitral inflow 
deceleration (E DT) and the ration between early (E) and atrial (A) mitral inflow velocities (E/A-ratio). Invasive pressures and continuous cardiac 
output monitoring were obtained by LiDCO pulse power analysis facilitating estimates of pulse pressure, stroke volume index (SVI) and systemic 
vascular resistance (SVRI). 
Results:  The TAVI procedure was successful in all patients and induced an immediate improvement in global LV systolic function, demonstrated 
by an increase in S’ from -2.6±0.9 at BL to -3.6±0.9 cm/s 15 min post TAVI (p=0.003). E DT decreased from 286±131 to 167±78 ms (p=0.011), 
while E/A-ratio increased from 2.0±1.1 to 3.1±1.6 cm/s (p=0.021), indicating enhanced diastolic relaxation post valve delivery. There was a marked 
increase in pulse pressure (44±4 mmHg to 60±9 mmHg, p=0.005), despite unchanged SVRI (1775±716 to 1583±359 d.s.cm-5m-2, p=0.43). No 
significant changes were observed in heart rate (72±15 to 79±17 beats/min), mean arterial blood pressure (65±12 to 70±5 mmHg), central venous 
pressure (10±4 to 12±2 mmHg) or SVI (34±12 to 37±14 mL/m2).
Conclusions:  This study demonstrates that LV systolic contraction and even diastolic relaxation are immediately improved following TAVI in high 
risk patients. Further studies need to focus on the prognostic value of these results. 
